Lynne Millar-Kelly
Director/Miembro de la Junta en Ipsen Bioinnovation Ltd. .
Origen de la red de primer grado Lynne Millar-Kelly.
Entidad | Tipo de entidad | Industria | |
---|---|---|---|
Ipsen Bioinnovation Ltd.
Ipsen Bioinnovation Ltd. BiotechnologyHealth Technology Ipsen Bioinnovation Ltd. Engages in the research and development of pharmaceutical products. The company was founded in 2005 and is headquartered in Abingdon, the United Kingdom.
2
| Subsidiary | Biotechnology | 2 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Lynne Millar-Kelly a través de su red personal
Empresa | Sector | Personas relacionadas | Puesto principal |
---|---|---|---|
Ipsen Biopharm Ltd.
Ipsen Biopharm Ltd. Pharmaceuticals: MajorHealth Technology Part of Ipsen SA, Ipsen Biopharm Ltd. is a British biopharmaceutical company that aims to prolong patients' lives, improve health outcomes, and create a positive impact for patients and society. Founded in 1982, the company is based in Wrexham, UK. Ipsen specializes in the fields of oncology, neuroscience, and rare disease, and creates and manufactures pharmaceutical products to improve patients' lives through research and innovation. | Pharmaceuticals: Major | Director/Board Member | |
Ipsen NV
Ipsen NV Pharmaceuticals: MajorHealth Technology Part of Ipsen SA, Ipsen NV is a Belgian biopharmaceutical company that improves patients' lives through research and innovation in oncology, rare disease, and neuroscience. Founded in 1982, the company is based in Merelbeke, Belgium. Ipsen is a global mid-sized biopharmaceutical company that focuses on improving patients' lives through its research and innovation in the field of oncology, rare diseases, and neuroscience. | Pharmaceuticals: Major | Director/Board Member |
Estadísticas
Internacional
Reino Unido | 2 |
Bélgica | 2 |
Sectorial
Health Technology | 3 |
Operativa
Director/Board Member | 4 |
Las relaciones más conectadas
- Bolsa de valores
- Insiders
- Lynne Millar-Kelly
- Conexiones Empresas